GPR30 Activation Promotes the Progression of Gastric Cancer and Plays a Significant Role in the Anti-GC Effect of Huaier

Table 2

The correlations between the GPR30 expression levels and the clinicopathological features of GC patients.

	GPR30 expression		Total	χ2	value
	High	Low
Age (year)
<66	22	21	43	0.788	0.375
≥66	29	19	48
Sex
Female	14	5	19	3.033	0.082
Male	37	35	72
Tumor size (cm)
<5 cm	23	29	52	6.873	0.009
≥5 cm	28	11	39
Grade of differentiation
Well/moderate	22	13	35	1.072	0.301
Poor/not	29	27	56
T Stage
T1/T2	4	7	11	1.163	0.281
T3/T4	47	33	80
N stage
N0/N1	18	17	35	0.492	0.483
N2/N3	33	23	56
M Stage
M0	48	40	88	2.433	0.119
M1	3	0	3
TNM stage
Ι/II	15	11	26	0.040	0.841
III/IV	36	29	65
CEA (ng/ml)
<5	41	32	73	0.002	0.963
≥5	10	8	18
HER2
Positive	7	2	9	1.061	0.303
Negative	44	38	82
PD-1
Positive	13	3	16	2.859	0.091
Negative	38	37	75

.